www.medisonpharma.com
Open in
urlscan Pro
213.8.29.114
Public Scan
URL:
https://www.medisonpharma.com/
Submission: On May 06 via manual from DE — Scanned from DE
Submission: On May 06 via manual from DE — Scanned from DE
Form analysis
0 forms found in the DOMText Content
* About Us * Our Markets * Careers * Newsroom * Contact Us * Linkedin * © Copyright 2021 © Medison Pharma. All Rights Reserved. ALWAYS AHEAD MEDISON IS A GLOBAL PHARMA COMPANY PROVIDING ACCESS TO HIGHLY INNOVATIVE THERAPIES TO PATIENTS IN INTERNATIONAL MARKETS. MEDISON CREATED THE FIRST MULTI-REGIONAL COMMERCIALIZATION PLATFORM TO ACCELERATE ACCESS TO HIGHLY INNOVATIVE THERAPIES DEVELOPED BY LEADING BIOTECH AND PHARMA COMPANIES, HELPING TO SAVE LIVES OF PATIENTS IN INTERNATIONAL MARKETS Learn More OUR PARTNERS A UNIFIED ALLIANCE ACROSS MARKETS Medison is changing the commercialization paradigm for highly innovative therapies in international markets. An affiliate-like multi-regional partnership enables emerging biotech companies to accelerate product launches in international markets while preserving their bandwidth to focus on main markets. Learn More A COMPREHENSIVE COMMERCIALIZATION SUITE Medison’s unique set of expertise, centralized alliance management capabilities, global infrastructure and affiliate-like partnership model expands the geographic reach of emerging biotech companies. REGULATION & MARKET ACCESS Applying in-depth knowledge and expertise in regulatory frameworks and market access processes to ensure that high budget, innovative products are reimbursed and made available to patients. EARLY ACCESS PROGRAMS Navigating local access complexities for Medison’s partners to make their breakthrough therapies available for patients as quickly as possible. MEDICAL AFFAIRS Applying scientific and medical know-how, as well as ties in the academic, scientific and medical arenas to gain and disseminate insights and knowledge on cutting-edge therapies. MARKETING & SALES Empowering physicians to provide the latest and most suitable therapies to patients by facilitating a customer-oriented approach and access to up-to-date information. PATIENT SUPPORT PROGRAMS Leveraging the latest therapies, techniques and clinical resources to train and support patients, care partners and healthcare professionals, as well as improve patient engagement and medication-taking behavior. DISTRIBUTION & LOGISTICS Providing Medison’s partners with the convenience and peace of mind of a complete end-to-end service, across all stages, from post-production to delivery to patients. A COMPREHENSIVE COMMERCIALIZATION SUITE Medison’s unique set of expertise, centralized alliance management capabilities, global infrastructure and affiliate-like partnership model expands the geographic reach of emerging biotech companies. REGULATION & MARKET ACCESS Applying in-depth knowledge and expertise in regulatory frameworks and market access processes to ensure that high budget, innovative products are reimbursed and made available to patients. EARLY ACCESS PROGRAMS Navigating local access complexities for Medison’s partners to make their breakthrough therapies available for patients as quickly as possible. MEDICAL AFFAIRS Applying scientific and medical know-how, as well as ties in the academic, scientific and medical arenas to gain and disseminate insights and knowledge on cutting-edge therapies. MARKETING & SALES Empowering physicians to provide the latest and most suitable therapies to patients by facilitating a customer-oriented approach and access to up-to-date information. PATIENT SUPPORT PROGRAMS Leveraging the latest therapies, techniques and clinical resources to train and support patients, care partners and healthcare professionals, as well as improve patient engagement and medication-taking behavior. DISTRIBUTION & LOGISTICS Providing Medison’s partners with the convenience and peace of mind of a complete end-to-end service, across all stages, from post-production to delivery to patients. OUR LATEST NEWS Read More 28/03/22 Hansa Biopharma and Medison Pharma announce marketing authorization in Israel for Idefirix[®] (imlifidase) for desensitization treatment of highly sensitized kidney transplant patients 15/03/22 BeiGene and Medison Announce Approval and National Reimbursement in Israel for BRUKINSA® (zanubrutinib) for the Treatment of Waldenström’s Macroglobulinemia 26/01/22 Victor Papamoniodis Joins Medison Pharma as VP International Markets Read More Always Ahead * Home * About Us * Medison Ventures * Compliance * Our Markets * Newsroom * Careers * Contact Us * linkedin * Privacy Policy * Cookies Policy * Terms of Use © Copyright 2021 © Medison Pharma. All Rights Reserved.